Sorbonne Université, Institut du Cerveau, Paris Brain Institute, ICM, CNRS, InriaInserm, AP-HP, Hôpital de La Pitié Salpêtrière, 75013, Paris, France.
Laboratoire d'Imagerie Biomédicale, Sorbonne Université, CNRS, INSERM, Paris, France.
J Neurol. 2023 Dec;270(12):5903-5912. doi: 10.1007/s00415-023-11932-7. Epub 2023 Aug 24.
Studies showed the impact of sex and onset site (spinal or bulbar) on disease onset and survival in ALS. However, they mainly result from cross-sectional or survival analysis, and the interaction of sex and onset site on the different proxies of disease trajectory has not been fully investigated.
We selected all patients with repeated observations in the PRO-ACT database. We divided them into four groups depending on their sex and onset site. We estimated a multivariate disease progression model, named ALS Course Map, to investigate the combined temporal changes of the four sub-scores of the revised ALS functional rating scale (ALSFRSr), the forced vital capacity (FVC), and the body mass index (BMI). We then compared the progression rate, the estimated age at onset, and the relative progression of the outcomes across each group.
We included 1438 patients from the PRO-ACT database. They were 51% men with spinal onset, 12% men with bulbar onset, 26% women with spinal onset, and 11% women with bulbar onset. We showed a significant influence of both sex and onset site on the ALSFRSr progression. The BMI decreased 8.9 months earlier (95% CI [3.9, 13.8]) in women than men, after correction for the onset site. Among patients with bulbar onset, FVC was impaired 2.6 months earlier (95% CI [0.6, 4.6]) in women.
Using a multivariable disease modelling approach, we showed that sex and onset site are important drivers of the progression of motor function, BMI, and FVC decline.
研究表明,性别和发病部位(脊髓或延髓)对 ALS 的发病和生存有影响。然而,这些研究主要来自于横断面或生存分析,性别和发病部位对疾病轨迹不同指标的相互作用尚未得到充分研究。
我们从 PRO-ACT 数据库中选择了所有有重复观测的患者。根据他们的性别和发病部位将他们分为四组。我们估计了一个多变量疾病进展模型,命名为 ALS 病程图,以研究修订后的 ALS 功能评定量表(ALSFRSr)的四个子评分、用力肺活量(FVC)和体重指数(BMI)的综合时间变化。然后,我们比较了每个组的进展速度、估计的发病年龄和结局的相对进展。
我们纳入了 PRO-ACT 数据库中的 1438 名患者。他们中 51%为男性,发病部位为脊髓;12%为男性,发病部位为延髓;26%为女性,发病部位为脊髓;11%为女性,发病部位为延髓。我们发现性别和发病部位对 ALSFRSr 进展有显著影响。校正发病部位后,女性的 BMI 下降提前了 8.9 个月(95%CI[3.9, 13.8])。在延髓发病的患者中,女性的 FVC 受损提前了 2.6 个月(95%CI[0.6, 4.6])。
使用多变量疾病建模方法,我们发现性别和发病部位是运动功能、BMI 和 FVC 下降进展的重要驱动因素。